Blue Biofuels, Inc. (BIOF) stock
BIOFOTCIndustrial Organic ChemicalsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.11+0.00 (+1.77%)
Close on Oct 19, 2026Market cap $35.14MP/E –Yield –
Blue Biofuels r&d expenses
Research and development expenses are spending on new products and technology.
Blue Biofuels's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.30M, up 2.1% year over year. For fiscal 2025 it was $2.31M, down 1.0% from the year before. The highest annual figure on record is $2.35M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.31M | -1.0% |
| FY2024 | Dec 31, 2024 | $2.33M | +25.9% |
| FY2023 | Dec 31, 2023 | $1.85M | -21.3% |
| FY2022 | Dec 31, 2022 | $2.35M | +113.0% |
| FY2021 | Dec 31, 2021 | $1.10M | +44.6% |
| FY2020 | Dec 31, 2020 | $763.16K | -4.3% |
| FY2019 | Dec 31, 2019 | $797.86K | +8.3% |
| FY2017 | Dec 31, 2017 | $736.75K | +5.4% |
| FY2016 | Dec 31, 2016 | $698.79K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $431.20K | -8.5% |
| Q1 FY2026 | Mar 31, 2026 | $384.91K | +9.8% |
| Q4 FY2025 | Dec 31, 2025 | $997.49K | -2.2% |
| Q3 FY2025 | Sep 30, 2025 | $485.68K | +18.2% |
| Q2 FY2025 | Jun 30, 2025 | $471.47K | +61.8% |
| Q1 FY2025 | Mar 31, 2025 | $350.71K | -42.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.02M | +838.4% |
| Q3 FY2024 | Sep 30, 2024 | $410.81K | +39.9% |
| Q2 FY2024 | Jun 30, 2024 | $291.39K | -61.8% |
| Q1 FY2024 | Mar 31, 2024 | $607.64K | -11.2% |
| Q4 FY2023 | Dec 31, 2023 | $108.65K | -61.1% |
| Q3 FY2023 | Sep 30, 2023 | $293.67K | -27.3% |
| Q2 FY2023 | Jun 30, 2023 | $762.71K | +74.7% |
| Q1 FY2023 | Mar 31, 2023 | $684.56K | -44.4% |
| Q4 FY2022 | Dec 31, 2022 | $279.43K | -22.1% |
| Q3 FY2022 | Sep 30, 2022 | $404.16K | +75.8% |
| Q2 FY2022 | Jun 30, 2022 | $436.48K | +74.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.23M | +364.1% |
| Q4 FY2021 | Dec 31, 2021 | $358.65K | +293.1% |
| Q3 FY2021 | Sep 30, 2021 | $229.92K | +157.8% |
| Q2 FY2021 | Jun 30, 2021 | $249.79K | -49.2% |
| Q1 FY2021 | Mar 31, 2021 | $265.07K | +192.5% |
| Q4 FY2020 | Dec 31, 2020 | $91.24K | +13.3% |
| Q3 FY2020 | Sep 30, 2020 | $89.19K | -21.0% |
| Q2 FY2020 | Jun 30, 2020 | $492.12K | +503.6% |
| Q1 FY2020 | Mar 31, 2020 | $90.62K | -53.7% |
| Q2 FY2018 | Jun 30, 2018 | $80.53K | – |
| Q1 FY2018 | Mar 31, 2018 | $112.88K | – |
| Q2 FY2017 | Jun 30, 2017 | $81.53K | – |
| Q1 FY2017 | Mar 31, 2017 | $195.73K | – |
See a number that looks wrong?